Edwards Lifesciences Corp. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Edwards Lifesciences Corp. (EW) shares rose 3.20% to $88.82, outperforming the broader market's gains. The stock closed 7.76% below its 52-week high of $96.29. While competitors like Abbott and Medtronic saw modest gains, Stryker surged 4.76%. Trading volume was lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Edwards Lifesciences Corp. (EW) rose 3.20% to $88.82 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.48% to 7,600.50 and the Dow Jones Industrial Average rising 1.32% to 53,178.41.
Edwards Lifesciences Corp. closed 7.76% short of its 52-week high of $96.29, which the company reached on July 7th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Abbott Laboratories (ABT) rose 1.34% to $107.12, Medtronic PLC (MDT) rose 1.51% to $86.68, and Stryker Corp. (SYK) rose 4.76% to $341.20.
Trading volume (3.9 M) remained 1.3 million below its 50-day average volume of 5.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 3, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-03-26 1651ET